2HFR
solution structure of antimicrobial peptide Fowlicidin 3
2HFR の概要
エントリーDOI | 10.2210/pdb2hfr/pdb |
関連するPDBエントリー | 2amn |
分子名称 | Fowlicidin-3 (1 entity in total) |
機能のキーワード | alpha helix, antimicrobial protein |
細胞内の位置 | Secreted (By similarity): Q2IAL6 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 3101.78 |
構造登録者 | Bommineni, Y.R.,Dai, H.,Gong, Y.,Prakash, O.,Zhang, G. (登録日: 2006-06-26, 公開日: 2007-04-17, 最終更新日: 2024-05-29) |
主引用文献 | Bommineni, Y.R.,Dai, H.,Gong, Y.X.,Soulages, J.L.,Fernando, S.C.,Desilva, U.,Prakash, O.,Zhang, G. Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities. Febs J., 274:418-428, 2007 Cited by PubMed Abstract: Cathelicidins are an important family of cationic host defense peptides in vertebrates with both antimicrobial and immunomodulatory activities. Fowlicidin-1 and fowlicidin-2 are two newly identified chicken cathelicidins with potent antibacterial activities. Here we report structural and functional characterization of the putatively mature form of the third chicken cathelicidin, fowlicidin-3, for exploration of its therapeutic potential. NMR spectroscopy revealed that fowlicidin-3 comprises 27 amino-acid residues and adopts a predominantly alpha-helical structure extending from residue 9 to 25 with a slight kink induced by a glycine at position 17. It is highly potent against a broad range of Gram-negative and Gram-positive bacteria in vitro, including antibiotic-resistant strains, with minimum inhibitory concentrations in the range 1-2 microM. It kills bacteria quickly, permeabilizing cytoplasmic membranes immediately on coming into contact with them. Unlike many other host defense peptides with antimicrobial activities that are diminished by serum or salt, fowlicidin-3 retains bacteria-killing activities in the presence of 50% serum or physiological concentrations of salt. Furthermore, it is capable of suppressing lipopolysaccharide-induced expression of proinflammatory genes in mouse macrophage RAW264.7 cells, with nearly complete blockage at 10 microM. Fowlicidin-3 appears to be an excellent candidate for future development as a novel antimicrobial and antisepsis agent, particularly against antibiotic-resistant pathogens. PubMed: 17229147DOI: 10.1111/j.1742-4658.2006.05589.x 主引用文献が同じPDBエントリー |
実験手法 | SOLUTION NMR |
構造検証レポート
検証レポート(詳細版)をダウンロード